Benjamin Izar
Impact in
- Biophysics top 1%
- Cell Image Analysis Techniques
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 42
- Cancer Immunotherapy and Biomarkers 23
- CAR-T cell therapy research 13
-
- Melanoma and MAPK Pathways 8
- Single-cell and spatial transcriptomics 8
- Co-authors
- Peter K. Sorger (5 shared papers)Jia‐Ren Lin (4 shared papers)Parin Shah (8 shared papers)Sandro Santagata (3 shared papers)Shu Wang (2 shared papers)Shaolin Mei (2 shared papers)Clarence Yapp (1 shared paper)Levi A. Garraway (7 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Research (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)Clinical Cancer Research (2 papers)Cancer Cell (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Benjamin Izar
55 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Biophysics 199
- Oncology 582
- Cancer Research 248
- Immunology 328
- Molecular Biology 806
Countries citing papers authored by Benjamin Izar
This map shows the geographic impact of Benjamin Izar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Izar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Izar more than expected).
Fields of papers citing papers by Benjamin Izar
This network shows the impact of papers produced by Benjamin Izar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Izar. The network helps show where Benjamin Izar may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Izar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes Hit paper breakdown → | 2018 | 376 |
| 2 | 2017 | 158 | |
| 3 | 2015 | 88 | |
| 4 | 2013 | 84 | |
| 5 | 2011 | 73 | |
| 6 | 2019 | 72 | |
| 7 | 2014 | 72 | |
| 8 | 2012 | 50 | |
| 9 | 2022 | 39 | |
| 10 | 2020 | 39 | |
| 11 | 2019 | 36 | |
| 12 | 2018 | 35 | |
| 13 | 2021 | 34 | |
| 14 | 2021 | 34 | |
| 15 | 2024 | 33 | |
| 16 | 2020 | 30 | |
| 17 | 2022 | 29 | |
| 18 | 2016 | 27 | |
| 19 | 2013 | 25 | |
| 20 | 2017 | 19 |
About Benjamin Izar
Benjamin Izar is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Cancer Genomics and Diagnostics (13 papers), CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (9 papers), Melanoma and MAPK Pathways (8 papers), Single-cell and spatial transcriptomics (8 papers), Renal cell carcinoma treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Biophysics (199 citations), Oncology (582 citations), Cancer Research (248 citations), Immunology (328 citations) and Molecular Biology (806 citations). Benjamin Izar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Peter K. Sorger, Jia‐Ren Lin, Parin Shah, Sandro Santagata, Shu Wang, Shaolin Mei, Clarence Yapp, Levi A. Garraway, Asaf Rotem and Torsten Hain. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.